The Global Market for Feed Enzymes 2018-2023 featuring

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
75
The Global Market for Feed Enzymes 2018-2023 featuring Tyson Food, ADM, Land O'Lakes, Cargill, BASF, DowDuPont, Genecor International, and more

Dublin, Aug. 30, 2018 (GLOBE NEWSWIRE) -- The "Feed Enzyme Market by Type, By Consumer Livestock and By Geography - Global Driver, Restraints, Opportunities, Trends, and Forecast to 2023" report has been added to ResearchAndMarkets.com's offering. According to the report, the global feed enzyme market is expected to grow at a CAGR of 7.3% during the forecast period. It is expected to reach $1.51 billion by 2023. The Asia Pacific has the fastest growth rate and is expected to move towards greater adoption of feed enzyme technology. This will directly boost the consumption value majorly coming from China, Australia, and Latin America.

Globally, the demand for feed enzyme is high in economically developing countries, whereas the developed regions are moving towards saturation. Extensive consumption of enzymes comes from poultry and swine segments due to better adoption rate in the industry. Further research and developments in enzyme biotechnology for stabilizing enzyme effectiveness is expected to boost the growth in the next five years. The regional demand for feed enzyme is growing, especially in the Asia Pacific and Latin American regions. This growth is supported by the increasing awareness for enzyme biotechnology and high consumption rate for animal products in these regions. Currently, Europe is the global leader in the feed enzyme market from the demand side. The European region has strict policies for the animal product consumption, providing the maximum usage of high-quality feed enzymes.

From the supplier side, the Asia Pacific followed by North America are the market leaders. Developing and underdeveloped markets like Latin America, Middle East & Africa are also witnessing capital investments for research and development for product development of feed enzymes which is increasing the regional competition.

Key Topics Covered

1 Report Outline 1.1 Introduction 1.2 Report Scope 1.3 Market Definition 1.4 Research Methodology 1.4.1 Data Collation & In-House Estimation 1.4.2 Market Triangulation 1.4.3 Forecasting 1.5 Study Declarations 1.6 Report Assumptions 1.7 Stakeholders 2 Executive Summary 2.1 Asia Pacific is the fastest growing region in Feed enzyme Market 2.2 Poultry industry fueling the growth of feed enzyme 3 Market Positioning 3.1 Total Addressable Market (TAM): Feed additive market 3.1.1 Market Overview 3.1.2 Major Trends 3.2 Segmented Addressable Market (SAM) 3.3 Related Markets 4 Market Outlook 4.1 Overview 4.2 Value Chain Analysis 4.3 PESTLE Analysis 4.4 Porter 5 (Five) Forces 4.5 Patent Analysis 5 Market Characteristics 5.1 Market Segmentation 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Increasing penetration of feed enzyme towards new markets 5.2.1.2 Innovation in new biotechnology formulations 5.2.1.3 Good efficacy in terms of product usage and returns 5.2.2 Restraints 5.2.2.1 High product prices and limited players 5.2.2.2 Changing geo-political structure of various countries affecting the market 5.2.2.3 Limited understanding of application & usage in underdeveloped countries 5.2.3 Opportunities 5.2.3.1 Need for better and cost-effective feed enzyme 5.2.3.2 Large untapped market in developing and underdeveloped countries 5.2.4 DRO - Impact Analysis 6 By Type: Market Size and Analysis 6.1 Overview 6.2 Phytase 6.3 Protease 6.4 Carbohydrase 6.5.1 Carbohydrase type (Amylase, Xylanases, Mannanases) 7 By Source: Market Size and Analysis 7.1.1 Overview 7.2 Microorganism 7.3 Plant 7.4 Animal 7.5 Vendor Profiles 7.5.1 Cargill Inc. 7.5.2 BASF SE 7.5.3 DowDuPont Inc. 7.5.4 Novozymes 7.5.5 Novus International Inc. 8 Consumer livestock: Market Size and Analysis 8.1 Overview 8.2 Ruminants 8.3 Poultry 8.4 Swine 8.5 Aquatic Animals 8.6 Customer Profiles 8.6.1 Tyson Food 8.6.2 Archer Daniel Midland Company 8.6.3 Land O'Lakes Inc 8.6.4 Nutrena 8.6.5 Provimi 9 Regions: Market Size and Analysis 10 Companies to Watch For 10.1 Archer Daniel Midland Company (ADM) 10.1.1.1 Overview 10.1.1.2 Archer Daniel Midland increases specialty feed ingredient portfolio targeting poultry & swine 10.2 Genencor International (DuPont) 10.2.1.1 Overview 10.2.1.2 Genencor International develops feed granules to protect active ingredients 11 Competitive Landscape 11.1 Competitor Comparison Analysis 11.2 Market Landscape 11.2.1 Mergers, Acquisitions & Joint Ventures 11.2.2 Divestiture & Divestment 11.2.3 Expansion 12 Expert's Views

For more information about this report visit https://www.researchandmarkets.com/research/q...arket?w=12

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Animal Feedstuffs, Enzymes

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading